Tattoo ink found to be source of M. chelonae outbreak

August 23, 2012

(HealthDay)—Premixed tattoo ink has been found to be the source of an outbreak of Mycobacterium chelonae in 19 patients in Rochester, N.Y., according to a study published online Aug. 22 in the New England Journal of Medicine.

Byron S. Kennedy, M.D., Ph.D., from the Monroe County Department of Public Health in Rochester, N.Y., and colleagues analyzed data from patient interviews and conducted histopathological testing of skin-biopsy specimens with acid-fast bacilli smears and microbial cultures. DNA sequencing was performed as well as cultures of the ink and ingredients used in the preparation and packaging of ink. Tattoo parlor water and faucets were also assessed.

The researchers found that a persistent, raised erythematous rash developed in the tattoo area of 19 people (13 men and six women; average age, 35 years) within three weeks of receiving a tattoo from a single artist who used premixed gray ink. Abnormalities in skin-biopsy specimens were present in all 17 patients biopsied. Mycobacterium chelonae was found in 14 patients and confirmed with DNA sequencing. With appropriate , the condition improved in 18 of the 19 patients.

"The premixed ink was the common source of infection in this ," the authors write.

Explore further: Tattoos linked to rare skin infection in US

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Tattoos linked to rare skin infection in US

August 10, 2011
At least two men may have come down with a rare bacterial skin infection that is hard to treat with antibiotics after getting tattoos at a store in Seattle, US health authorities said Wednesday.

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.